Send the following on WhatsApp
Continue to ChatPROLONGED THERAPY OF HEPATITIS DELTA FOR 96 WEEKS WITH PEGYLATED-INTERFERON-alpha-2a PLUS TENOFOVIR OR PLACEBO DOES NOT PREVENT HDV RNA RELAPSE AFTER TREATMENT: THE HIDIT-2 STUDY - https://avesis.uludag.edu.tr/yayin/45f7bf03-80dc-4784-907a-d38f2ed70c27/prolonged-therapy-of-hepatitis-delta-for-96-weeks-with-pegylated-interferon-alpha-2a-plus-tenofovir-or-placebo-does-not-prevent-hdv-rna-relapse-after-treatment-the-hidit-2-study